Systematic review of HIV and HCV infection among drug users in China
- 1 June 2009
- journal article
- review article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 20 (6) , 399-405
- https://doi.org/10.1258/ijsa.2008.008362
Abstract
To determine the HIV and hepatitis C virus (HCV) geographical distribution among drug users in China, a systematic literature review of 40 peer-reviewed publications (comprising 15,565 drug users) was conducted. Of the total drug users, 10,724 were found to be injection drug users (IDUs) and 4841 were non-injection drug users (non-IDUs). Various studies identified that among IDUs and non-IDUs, the overall HIV prevalence rates were 12.55% and 1.05%, and the HCV prevalence rates were 66.97% and 18.30%, respectively. The HIV prevalence rate ranged from 0% (Anhui and Inner Mongolia) to 52.51% (Yunnan) among IDUs, and from 0% to 19.80% among non-IDUs correspondingly. The HCV prevalence rate ranged from 11.43% (Shannxi) to 90.77% (Hubei) among IDUs, and from 0% (Anhui) to 40.00% (Fujian) among non-IDUs. Based on the high prevalence of HIV and HCV among drug users, scaling-up harm reduction was required from ‘heroin trafficking areas’ to other areas in China.Keywords
This publication has 12 references indexed in Scilit:
- Global estimates of prevalence of HCV infection among injecting drug usersInternational Journal of Drug Policy, 2007
- HIV, injecting drug use and harm reduction: a public health responseAddiction, 2007
- Rapid scale up of harm reduction in ChinaInternational Journal of Drug Policy, 2007
- Evolution of China's response to HIV/AIDSThe Lancet, 2007
- HIV Testing in ChinaScience, 2006
- Recent trends in drug abuse in China1Acta Pharmacologica Sinica, 2006
- Coinfection with HIV and Hepatitis C Virus among Injection Drug Users in Southern ChinaClinical Infectious Diseases, 2005
- Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of ChinaWorld Journal of Gastroenterology, 2004
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyThe Lancet, 2000
- TT Virus Infection Among IVDUs in South western ChinaScandinavian Journal of Infectious Diseases, 1999